PRESTIGE BIOPHARMA 프레스티지바이오파마 Prestigebiopharma

Innovation for Life

Developing Innovative drugs, Biosimilars, Platforms, and Diagnostic technologies to improve lives.

Advancing Antibody Science

Advancing antibody drugs and biosimilars to address unmet medical needs.

Creating Value for a Healthier Life

Improving patient access through cost-effective, high-quality biosimilars.

PRESTIGE BIOPHARMA

PRESTIGE BIOPHARMA IDC

PRESTIGE BIOLOGICS

7

Beyond technological discovery, expanding access to care for patients around the world

Innovative Drug

Development of First-in-Class therapeutics for unmet diseases

Biosimilar

Prominent Biosimilars pipelines for accelerating market access

Platform Technology

A drug delivery platform that enhances treatment convenience

Diagnostics

Diagnostics for Pancreatic cancer by detecting PAUF

Prestige News

Total 79

Number	Thumbnail	Title	Author	Date	Votes	Views
79		Prestige Biopharma Participates in CPHI Milan 2026 to Expand Global Partnerships 김** \| 2026.10.07 \| Votes 0 \| Views 167	김**	2026.10.07	0	167
78		Prestige Biopharma IDC's Taeheung Kang, Director of Drug Development Division: 'Additional Pipelines Ready… Accelerating Resear 김** \| 2026.10.01 \| Votes 0 \| Views 385	김**	2026.10.01	0	385
77		Prestige Biopharma Appoints Neil O’Connor as Board Director, Strengthening Expertise in CMC and Quality Management 김** \| 2026.09.30 \| Votes 0 \| Views 336	김**	2026.09.30	0	336
76		Prestige Biopharma Receives Brazilian Marketing Authorization for Herceptin Biosimilar Tuznue 김** \| 2026.09.28 \| Votes 0 \| Views 567	김**	2026.09.28	0	567
75		Prestige Biopharma’s Tuznue Receives Marketing Authorization in Trinidad and Tobago 김** \| 2026.09.18 \| Votes 0 \| Views 792	김**	2026.09.18	0	792
74		Prestige Biopharma IDC Obtains ISO 14001 and ISO 45001 Certifications 김** \| 2026.09.17 \| Votes 0 \| Views 586	김**	2026.09.17	0	586
73		Prestige Biopharma Successfully Concludes ‘Prestige Symposium’ on Aging 김** \| 2026.09.09 \| Votes 0 \| Views 1181	김**	2026.09.09	0	1181
72		Prestige Biopharma IDC CEO Ko Sang-seok Purchases Company Shares on the Open Market 김** \| 2026.09.03 \| Votes 0 \| Views 1432	김**	2026.09.03	0	1432
71		Prestige Biopharma’s Tuznue Secures Brazilian GMP Certification, Supporting Latin American Approval Process 김** \| 2026.08.25 \| Votes 0 \| Views 2075	김**	2026.08.25	0	2075
70		Prestige Biopharma Files Patent Application for TASA™, a Blood-Based Pancreatic Cancer Diagnostic Platform 김** \| 2026.08.12 \| Votes 0 \| Views 2104	김**	2026.08.12	0	2104

Read Prestige news >>